Tuesday, December 19, 2017 1:10:57 PM
Business Description
The Company is now in process of seeking a merger or acquisition candidate. Effective October 9, 2017 the PSA Agreement with Cantech Pharma, inc. has been rescinded do inability to proceed with the license for Mexico that previously had focused on its immunotherapeutic based technology specific to Cancer indication. Cantech Holding, Inc., f/k/a Reve Technologies, Inc., f/k/a Bassline Productions, Inc. was formerly involved as an immunotherapeutic based technology company focused on investing in development of, manufacture and commercialization of its then lead product Irreversible Pepsin Fraction (IPF) specific to the Cancer indication only, exclusively licensed for the United Mexican States.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM